Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep-Oct;25(5):792-793.
doi: 10.4103/aian.aian_629_22. Epub 2022 Oct 31.

Trail Toward Tenecteplase

Trilochan Srivastava  1 , Neetu Ramrakhiani  2 , Vikram Bohra  3
Affiliations
Editorial

Trail Toward Tenecteplase

Trilochan Srivastava et al. Ann Indian Acad Neurol. 2022 Sep-Oct.
No abstract available

PubMed Disclaimer

References

    1. Dhar N, Kumar M, Tiwari A, Desai I, Madhaw G, Kumar N. Tenecteplase and alteplase for thrombolysis of acute ischemic stroke within 4.5 hours:An efficacy and safety study. Ann Indian Academy Neurol. 2022;25:327–574. doi:10.4103/aian.aian_1127_21. - PMC - PubMed
    1. Guidelines for Prevention and Management of Stroke published by NPCDCS, Ministry of Health and Family Welfare, Govt. of India. 2019. Available from: https://main.mohfw.gov.in/Major- programmes/non-communicable-diseases-in... .
    1. Tanswell P, Modi N, Combs D, Danays T. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin Pharmacokinet. 2002;41:1229–45. - PubMed
    1. Huang X, Cheripelli BK, Lloyd SM, Kalladka D, Moreton FC, Siddiqui A, et al. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST):A phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 2015;14:368–76. - PubMed
    1. Logallo N, Novotny V, Assmus J, Kvistad CE, Alteheld L, Rønning OM, et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST):A phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 2017;16:781–8. - PubMed

Publication types